Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

46 results about "Parvovirus" patented technology

Parvovirus is the common name applied to all the viruses in the Parvoviridae taxonomic family, although it can also be used specifically for members of one of the two Parvoviridae subfamilies, the Parvovirinae, which infect vertebrate hosts. Members of the second subfamily, the Densovirinae, which infect invertebrate hosts, are more commonly referred to as densoviruses. In subfamily Parvovirinae there are eight genera, containing a total of 58 recognized species, while in subfamily Densovirinae there are 5 genera and a total of 21 species. These viruses have small genomes, encoding just two genes, and must rely on the synthetic machinery of their host cell for their own preferential replication. This means that many parvoviruses require host cells to enter S-phase before viral DNA replication can initiate, but they do not encode any gene products that can drive this transition. Parvoviruses overcome this problem in various ways: viruses in many genera simply wait within the cell for it to enter S-phase under its own cell cycle control, which means that they can only infect actively-dividing cell populations. In contrast, the so-called adeno-associated viruses (AAVs) from genus Dependoparvovirus must wait until the cell is co-infected by a helper DNA virus, commonly an adenovirus or herpes virus, which does encode gene products that can drive the cell into S-phase, allowing AAV infection to initiate and out-compete the helper virus. A third strategy is used by human bocavirus 1 (HBoV1) from genus Bocaparvovirus, which appears to invoke a specific DNA-damage response in its host cell that ultimately supports viral DNA amplification and progeny virus production.

Nylon 6 nanofiber virus-removing filtering membrane as well as preparation method and application thereof

The invention provides a nylon 6 nanofiber virus-removing filtering membrane and a preparation method and application thereof.The nylon 6 nanofiber virus-removing filtering membrane comprises a base material and a nylon 6 nanofiber membrane compounded to the surface of the base material, the average pore size of the virus-removing filtering membrane is 20 nm, the virus-removing filtering membrane plays a role in blocking parvoviruses, the surface of the virus-removing filtering membrane is charged, and the surface of the virus-removing filtering membrane is not prone to being damaged. Proteins with the same charges on the surface can be prevented from adhering to the surface of the fiber. In the preparation process of the virus-removing filtering membrane, the nylon 6 nanofibers with a certain diameter range are selected and compounded on the surface of the base material in a stable dispersion state, the uniform microporous virus-removing filtering membrane is prepared, the effect that parvoviruses are blocked and protein molecules are not easily intercepted is achieved, the hydrophilicity of the nylon 6 nanofibers is relatively good, and the virus-removing filtering membrane has a good application prospect. The non-specific adsorption of the filtering membrane on the protein is reduced; the nylon 6 nanofiber virus-removing filtering membrane can be applied to the field of biological medicine products, and has important significance on separation and purification of biological preparations.
Owner:WUHAN WEICHEN TECH CO LTD +1

Swine fever and porcine parvovirus bivalent subunit vaccine and preparation method thereof

The invention discloses a swine fever and porcine parvovirus bivalent subunit vaccine and a preparation method thereof. The vaccine comprises a first recombinant protein encoded by a first gene, a second recombinant protein encoded by a second gene and a pharmaceutically acceptable carrier. The first gene has a sequence as shown in SEQ ID NO: 1 or an increased or reduced sequence thereof. And the second gene has a sequence as shown in SEQ ID NO: 2 or an increased or reduced sequence thereof. An antigen E2 protein of a hog cholera virus (CSFV) and a VP2 protein of a porcine parvovirus (PPV) are taken as double targets, a recombinant SC-E2 protein with a SpyCatcher tag and a recombinant ST-VP2 protein with a SpyTag tag are respectively expressed in insect cells through a recombinant baculovirus vector, double-antigen covalent assembly is realized in vitro, and the constructed bivalent subunit vaccine can be used for simultaneously preventing and controlling two epidemic diseases and has a good application prospect. And the vaccine has the advantages of high safety, strong immunogenicity, high prevention and control efficiency, easiness in large-scale production and the like.
Owner:SUZHOU WOMEI BIOLOGY CO LTD

An amino acid sequence with steric hindrance effect and a preparation method thereof, a VP2 protein of recombinant porcine parvovirus and a nucleotide sequence thereof, and a virus-like particle assembled thereby

PendingCN122325561ANucleotideProtein structure
This invention belongs to the field of bioengineering and virus-like particle (VLP) construction technology, specifically relating to an amino acid sequence with steric hindrance effect and its preparation method, the VP2 protein of recombinant porcine parvovirus and its nucleotide sequence, and the virus-like particles assembled from it. An amino acid sequence with steric hindrance effect, SEQ ID NO: 1, is provided. This invention provides an amino acid sequence with steric hindrance effect, which is fused to the N-terminus of the wild-type VP2 protein to obtain a modified VP2 protein. During the critical phase of the assembly of the modified VP2 protein into VLPs, SEQ ID NO: 1 at the N-terminus, due to its steric hindrance effect, pre-occupies and physically seals the 5-fold pores of the capsid, ensuring that the host background nucleic acid cannot enter the particle interior. Through protein structure modification, nucleic acid entry into the particle interior is physically blocked from the source, resulting in a pure antigen with extremely high hollowing rate.
Owner:HENAN AGRICULTURAL UNIVERSITY

DNA impurities in a composition comprising a parvoviral virion

ActiveUS12674211B2DNACell biology
The current invention relates to nucleic acid impurities in a composition comprising a parvoviral vector. In particular, the current invention shows that DNA impurities are not randomly encapsulated within a parvoviral virion. The invention therefore relates to a method for identifying and quantifying a nucleic acid impurity in a composition comprising a parvoviral vector. Finally, the current invention relates to method of determining whether a composition comprising a parvoviral vector is regarded as clinically pure.
Owner:UNIQURE IP BV

Vaccine prepared from Graisseria parasuis SmpA protein and related tandem protein thereof and application of vaccine

The invention provides a vaccine prepared from Gleisseria parasuis SmpA protein and related tandem protein thereof and application, and belongs to the technical field of veterinary biological products. The invention relates to a vaccine prepared from a Gleisseria parasuis SmpA protein, and further relates to recombinant proteins SmpA-OppA1 and OppA1-SmpA which are expressed in a tandem manner, and recombinant proteins SmpA-PalA and PalA-SmpA which are expressed in a tandem manner, namely SmpA and OppA1 recombinant proteins SmpA-OppA1 and OppA1-SmpA. Experiment results show that the SmpA protein, the SmpA-OppA1 and OppA1-SmpA, and the SmpA-PalA and PalA-SmpA all have the obvious advantage and characteristic of strong immune protection efficacy, and after the SmpA protein, the SmpA-OppA1 and OppA1-SmpA as well as the SmpA-PalA and PalA-SmpA are mixed with an adjuvant, the prepared swine Graisseria subunit vaccine has the advantages of simple process and good safety, can effectively resist the infection of Graisseria parasuis, and lays a foundation for industrial production of the swine Graisseria subunit vaccine.
Owner:HENAN UNIV OF SCI & TECH

AAV vectors produced by insect cells comprising Rep52 and Rep78 coding sequences with differential codon biases

The present invention relates to production of proteins in insect cells whereby repeated coding sequences are used in baculoviral vectors. In particular the invention relates to the production of parvoviral vectors that may be used in gene therapy and to improvements in expression of the viral rep proteins that increase the productivity of parvoviral vectors.
Owner:UNIQURE IP BV

Quantitative PCR primers, probes, kits and applications for simian and cytomegalovirus

The application discloses quantitative PCR primers, probes, kits and application of monkey parvovirus and cytomegalovirus, relates to the technical field of pathogenic microorganism detection, and is characterized in that through deep alignment analysis on whole genomes of the monkey parvovirus and the monkey cytomegalovirus, two specific target regions specific to the two viruses, highly conservative and low in homology with other viruses are screened out, and two groups of primer probe combinations with high specificity and no mutual interference are designed; based on the two groups of primers and probes, a standardized kit with complete components and accurate proportion is constructed, and the kit comprises core components such as a fluorescence quantitative PCR premix and positive and negative controls; meanwhile, an optimized rapid quantitative detection method is established, through standard sample pretreatment, a precise reaction system, optimization of an amplification program and clear interpretation standards, the detection is completed within 2 hours, the detection lower limit is as low as 5 copies / µL, and the detection effect with 100% specificity is achieved.
Owner:SUZHOU XISHAN BIOLOGICAL TECH

Primer probe combination for detecting parvovirus B19

The invention discloses a primer probe combination for detecting parvovirus B19. According to the invention, a method for simultaneously detecting double targets of the NS1 gene and the VP1 gene of the B19 virus is established, the detection accuracy is improved, the clinical omission ratio is reduced, meanwhile, the result credibility is increased, and unnecessary confirmation experiments are reduced. Meanwhile, the method using the MGB-TaqMan fluorescent probe has the advantages of rapidness, sensitivity, easiness in operation and the like, the double-target synergism is good, and the clinical reinspection condition can be reduced.
Owner:NAT INST FOR FOOD & DRUG CONTROL

Methods, devices, kits and compositions for detecting tapeworm

Methods, devices, kits and compositions for detecting the presence or absence of one or more tapeworm coproantigens in a sample are disclosed herein. The methods, devices, kits and compositions of the present invention may be used to confirm the presence or absence of tapeworm in a fecal sample from a mammal and may also be able to distinguish between different tapeworm species and in the presence of one or more infections with helminths (such as roundworm, hookworm, whipworm and heartworm), Giardia and parvovirus. Confirmation of the presence or absence of tapeworm in the mammal may be made, for example, for the purpose of selecting an optimal course of treating the mammal and / or for the purpose of determining whether the mammal has been rid of the infection after treatment has been initiated.
Owner:IDEXX LABORATORIES INC

Modified capsid proteins for enhanced delivery of parvovirus vectors

This invention relates to modified parvovirus capsid proteins with enhanced transduction efficiency, viral vectors comprising the same, and methods of using the same for delivery of nucleic acids to a cell or a subject.
Owner:THE UNIV OF NORTH CAROLINA AT CHAPEL HILL

Egg yolk antibody for cat parvovirus and preparation method thereof

PendingCN121736088AEgg immunoglobulinsAnimal feeding stuffBiotechnologyFeline parvovirus
According to the present invention, the FPV-BJ strain (2 # seed virus) is adopted as the immunogen, and is inactivated to prepare the egg yolk antibody, the research results show that the egg yolk antibody with the FPV-HI titer of 1: 2048 can be obtained under the condition of the immunogen concentration of 105.0 TCID50 / ml, the obtained egg yolk antibody is higher than the existing reported level, and the egg yolk antibody can be further prepared into the feeding egg yolk antibody egg yolk powder for pet food, according to the present invention, the egg yolk antibody freeze-drying preparation or the egg yolk antibody injection preparation can be used as the drug, and the egg yolk antibody freeze-drying preparation is optimized, such that the treatment period and the treatment effect of the affected cat using the egg yolk antibody freeze-drying preparation or the egg yolk antibody injection preparation can be significantly improved; the symptom recovery time and the recovery time are shorter than those of sick cats without using the egg yolk antibody, so that the egg yolk antibody injection preparation prepared by the invention can effectively relieve clinical symptoms and greatly shorten the curing time.
Owner:BEIJING SHIHUA KANGYUAN BIOTECHNOLOGY CO LTD +1

Combined vaccine for swine erysipelothrix erysipelas, porcine parvovirus and leptospirosis

The present invention relates to a combination of a first vaccine comprising a non-replicating immunogen of porcine erysipelothrix sp. And a non-replicating immunogen of porcine parvovirus and a second vaccine comprising a non-replicating immunogen of leptospira sp. And the first vaccine and the second vaccine are jointly injected into corium layers of a first injection part and a second injection part of the pig at different points to prophylactically treat the pig so as to resist swine erysipelothrix erysipelas infection, porcine parvovirus infection and leptospirosis infection.
Owner:INTERVET INT BV

Construction method of recombinant canine distemper virus strain expressing mink parvovirus VP2 protein

The application provides a construction method of a recombinant canine distemper virus strain expressing mink parvovirus VP2 protein and relates to the technical field of genetic engineering. The construction method uses a mink canine distemper virus attenuated vaccine CDV3 strain as a basis, clones mink parvovirus VP2 genes into a canine distemper virus genome cDNA, and obtains a recombinant canine distemper virus rCDV3-mVP2 strain capable of simultaneously expressing CDV proteins and MEV VP2 proteins through virus reverse genetic technology, so as to provide a candidate vaccine strain for the research and development of a mink canine distemper and parvovirus enteritis double recombinant live vaccine.
Owner:HEILONGJIANG BAYI AGRICULTURAL UNIVERSITY

AAV-mediated expression using a synthetic promoter and enhancer

An isolated recombinant parvovirus vector comprising a synthetic enhancer comprising plurality of enhancer sequences operably linked to a promoter, and methods of using the vector, are provided.
Owner:THE UNIVERSITY OF IOWA RESEARCH

Sheldrake fibroblast passage cell line as well as preparation and domestication method and application thereof

The invention belongs to the field of cell biology, and relates to a shelduck fibroblast cell line which is finally obtained by performing primary culture, screening and optimized subculture on shelduck embryos serving as materials. The fibroblasts cultured by the method are slender, fusiform, triangular and irregular, and can be continuously subcultured for at least 82 generations; the shelduck fibroblast cell line is used for culturing waterfowl viruses such as duck plague virus, novel duck reovirus, duck tembusu virus, duck parvovirus and the like for the first time; compared with the existing duck-derived fibroblast culture, the duck-derived fibroblast culture medium has the advantages of high virus content and wide application range. The shelduck fibroblast cell line provided by the invention can provide a large amount of high-quality materials for scientific researches of cell engineering, molecular biology, immunology and the like; the method is used for culturing, separating and identifying poultry viruses, provides raw materials for development and production of poultry attenuated vaccines and inactivated vaccines, can shorten the production period and reduce the production cost, and has certain practical significance for large-scale production of vaccines.
Owner:CHINA INST OF VETERINARY DRUG CONTROL

RAA-LFD primer group and probe for pangolin parvovirus and application of RAA-LFD primer group and probe

The invention relates to an RAA-LFD primer group and a probe for pangolin parvovirus and application of the RAA-LFD primer group and the probe, and relates to the technical field of molecular biological detection. The pangolin parvovirus is detected on the basis of the RAA-LFD primer group and the probe, cross reaction with other common pathogens can be avoided, the problem of false positive caused by primer dimers is avoided, high specificity and sensitivity are achieved, and a method is provided for zoo rapid diagnosis, wild animal protection and the like.
Owner:SOUTH CHINA AGRICULTURAL UNIVERSITY

Proliferation culture method of high-titer mouse parvovirus

The invention relates to the field of biology, in particular to a proliferation culture method of high-titer mouse parvovirus. The method comprises the following steps: centrifuging mouse parvovirus harvest liquid to remove cell debris, taking supernatant, filtering with a filter membrane to remove bacteria, carrying out ultrafiltration concentration on a sample to be concentrated, and then carrying out conventional multiplication culture to obtain high-titer mouse parvovirus liquid. Compared with a traditional'conventional mouse parvovirus multiplication-concentration experiment 'mode, the multiplication culture method has the advantages that the yield of the viruses cannot be reduced, the quantity of the obtained viruses is large, the operation is simple, and the cost is low.
Owner:SHANDONG VOIN BIOTECHNOLOGY CO LTD

Double bifunctional vector for AAV generation

This invention provides nucleic acid constructs for the production of recombinant parvovirus gene therapy vectors. [Solution] A cell comprising one or more nucleic acid constructs, each comprising: a first expression cassette comprising a first promoter operably ligated to a nucleotide sequence encoding mRNA, the translation of which in a cell produces at least one of the parvovirus Rep78 and 68 proteins; a second expression cassette comprising a second promoter operably ligated to a nucleotide sequence encoding mRNA, the translation of which in a cell produces at least one of the parvovirus Rep52 and 40 proteins; a third expression cassette comprising a third promoter operably ligated to nucleotide sequences encoding parvovirus VP1, VP2 and VP3 capsid proteins; and a nucleotide sequence comprising a transgene adjacent to at least one parvovirus reverse terminal repeat sequence.
Owner:UNIQURE BIOPHARMA BV

Pig getah virus positive serum, preparation method and application thereof

PendingCN122145621ASerum immunoglobulinsMaterial analysisAnimal virusMaternal antibody
The application provides a pig getah virus positive serum and a preparation method and application, and belongs to the technical field of animal virology. The application provides a preparation method of a pig getah virus positive serum, wherein a CDCD pig is used as a host, neutralizing antibody titer obtained through multiple immunization of high-concentration antigen is greater than or equal to 1:512; the serum does not have cytotoxicity affecting cell culture; the CDCD pig is a pig free from maternal antibody interference, which is obtained through caesarean section, isolated feeding and artificial feeding; the positive serum does not detect pig pseudorabies virus, swine fever virus, porcine circovirus type 2, pig foot-and-mouth disease virus, bovine viral diarrhea virus, porcine infectious gastroenteritis virus, porcine epidemic diarrhea virus, porcine rotavirus, porcine parvovirus, porcine Japanese encephalitis virus antibody, and has the characteristics of high titer and no cytotoxicity.
Owner:CHINA INST OF VETERINARY DRUG CONTROL

Primer probe, kit, detection method and application for detecting mouse parvovirus

The invention discloses a primer probe for detecting mouse parvovirus, a kit, a detection method and application, and relates to the technical field of parvovirus detection.The primer probe comprises an external upstream primer, an external downstream primer, an internal upstream rhPCR primer, an internal downstream rhPCR primer, a first hydrolysis probe and a second hydrolysis probe, the nucleotide sequence of the external upstream primer is as shown in SEQ ID NO.1, the nucleotide sequence of the external downstream primer is as shown in SEQ ID NO.2, the nucleotide sequence of the internal upstream rhPCR primer is as shown in SEQ ID NO.3, and the nucleotide sequence of the internal downstream rhPCR primer is as shown in SEQ ID NO.4. The method has the advantages of ultrahigh sensitivity, strong anti-interference performance, single-tube reaction and no need of transfer, and effectively avoids cross contamination from a sample to a result lt; automatic compatibility is achieved, and the requirements of the 9101 method of the Chinese pharmacopoeia and the EMA / CHMP cell matrix guide are met.
Owner:NANJING ZHENGYANG BIOTECHNOLOGY CO LTD

Purification method of porcine parvovirus virus-like particles

PendingCN121914223AViral antigen ingredientsVirus peptidesLysisPorcine parvovirus
The invention relates to the technical field of virus purification, and particularly provides a purification method of porcine parvovirus virus-like particles. According to the present invention, Triton X-100 is adopted to perform cell lysis, a three-stage membrane filtration process is adopted to remove impurity components in the cell culture solution, and a PEG precipitation method is combined to purify the porcine parvovirus virus-like particles, such that the purity and the yield of the porcine parvovirus virus-like particles are furthest improved, the purity is 99%, and the recovery rate is 99%.
Owner:LUOYANG HUIZHONG BIOTECH +1

Primer, probe, kit and application for detecting simian parvovirus by microdroplet digital PCR

PendingCN122357804AGenomic cloneBioinformatics
This invention discloses primers, probes, kits, and applications for the detection of simian parvovirus using droplet digital PCR, relating to the field of biodetection technology. The primer-probe composition of this invention includes an upstream primer, a downstream primer, and a probe. When this composition is mixed with the nucleic acid template in the sample to be tested and enters the droplet digital PCR amplification system, the upstream and downstream primers specifically bind only to the perfectly matched sequence of the specific conserved region during the annealing stage. The probe can only hybridize with the region between the primers and be cleaved by Taq enzyme to release a fluorescent signal when the target sequence is present. Since the sequence of the homologous virus in the target region has a base mismatch with the primer-probe of this invention, it cannot achieve effective binding and extension, thus solving the risk of cross-reaction of homologous viruses from the source and realizing accurate and traceable quantitative detection of simian parvovirus nucleic acid copy number.
Owner:SUZHOU XISHAN BIOLOGICAL TECH

A pathogen multiplex PCR rapid detection method based on GenomeLabTM GeXP multiplex gene expression analysis technology

The application relates to the technical field of pathogen detection, and discloses a pathogen multiplex PCR rapid detection method based on GenomeLabTM GeXP multiplex gene expression analysis technology. A primer group composed of seven pairs of specific primers, one pair of positive control primers and one pair of universal primers is used to detect pathogens. The seven pairs of specific primers are respectively used for specifically combining with target genes of porcine fever virus, porcine reproductive and respiratory syndrome virus, pseudorabies virus, porcine parvovirus, porcine circovirus type 3, necrotic fusiform bacteria and porcine epidemic diarrhea virus. The 5' end of the universal upstream primer is provided with a fluorescent label. A two-step PCR amplification program is adopted, and rapid and accurate detection of the seven important pathogens, i.e. porcine fever virus, porcine reproductive and respiratory syndrome virus, pseudorabies virus, porcine parvovirus, porcine circovirus type 3, necrotic fusiform bacteria and porcine epidemic diarrhea virus, is successfully realized in one reaction system.
Owner:SICHUAN ANIMAL SCI ACAD

AAV vectors produced by insect cells comprising rep52 and rep78 coding sequences with differential codon biases

The present invention relates to production of proteins in insect cells whereby repeated coding sequences are used in baculoviral vectors. In particular the invention relates to the production of parvoviral vectors that may be used in gene therapy and to improvements in expression of the viral rep proteins that increase the productivity of parvoviral vectors.
Owner:UNIQURE IP BV

Cancer therapy involving car-engineered t-cells and parvovirus h-1

PendingAU2022230739B9ReceptorAntigen receptors
The present invention relates to compositions, methods, uses and kits for combination therapies involving immunotherapies, such as adaptive cell therapy, e.g., T cell therapy, and an oncolytic virus (particularly parvovirus H-1), for treating subjects with cancer. The T cell therapy includes cells that express recombinant receptors such as chimeric antigen receptors (CARs). In some embodiments, the cancer is a solid tumor or a hematological malignancy.
Owner:DEUTES KREBSFORSCHUNGSZENT STIFTUNG DES OFFENTLICHEN RECHTS

Device for detecting porcine reproductive disorder virus infectious disease

The invention relates to a device for detecting porcine reproductive and respiratory syndrome virus infectious diseases. Specific primers and fluorescent probes aiming at porcine reproductive and respiratory syndrome virus, porcine parvovirus and porcine circovirus type II are preloaded in a PCR (polymerase chain reaction) tube; the PCR reaction tubes are installed on the detection circular truncated cone in an annular array mode, the detection circular truncated cone is provided with the fluorescence excitation unit, the LED light source emits light with the corresponding wavelength, and the light is irradiated to each PCR reaction tube after being filtered by the optical filters which are arranged in the same annular array mode; all the PCR reaction tubes are driven by respective corresponding driving assemblies to synchronously move along the radial direction of the detection circular table; all the shading cylinders on the mounting disc above the detection circular table can completely cover the PCR reaction tube; a PCR reaction tube is correspondingly arranged on one side between each pair of photosensitive devices at the upper part of the disc edge of the mounting disc; and the photosensitive devices are used for sensing light filtered by the optical filter. The structure is simple and compact, and the detection efficiency and precision can be improved.
Owner:凉州区畜牧兽医技术推广中心